# Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone

> **NCT00771524** · PHASE1 · COMPLETED · sponsor: **Basilea Pharmaceutica** · enrollment: 22 (actual)

## Conditions studied

- Total Hip Replacement Surgery

## Interventions

- **DRUG:** Ceftobiprole

## Key facts

- **NCT ID:** NCT00771524
- **Lead sponsor:** Basilea Pharmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00771524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00771524, "Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00771524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*